Jump to content

Atenolol

From Simple English Wikipedia, the free encyclopedia
Atenolol
Clinical data
Trade namesTenormin, others
AHFS/Drugs.comMonograph
MedlinePlusa684031
License data
Pregnancy
category
  • AU:C
Routes of
administration
oral,Intravenous(IV)
Drug classSelectiveβ1receptorantagonist
ATC code
Legal status
Legal status
  • AU:S4(Prescription only)
  • In general: ℞ (Prescription only)
Pharmacokineticdata
Bioavailability40–50%
Protein binding6–16%[1]
MetabolismMinimal[1]
Onset of actionIV:<5 minutes[1]
Oral:<1 hour[1]
Eliminationhalf-life6–7 hours[1]
Duration of action>24 hours[1]
ExcretionUrine(>85%IV,50% oral)[1]
Identifiers
CAS Number
PubChemCID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
ECHA InfoCard100.044.941Edit this at Wikidata
Chemical and physical data
ChiralityRacemic mixture
(verify)

Atenolol (brand name:Tenormin)is abeta blockermedication which treats high blood pressure (hypertension), irregular heartbeats (arrhythmia) andangina.[2]

History and culture

[change|change source]

Atenolol was patented in 1969 and approved for medical use in 1975.[3]It is on theWorld Health Organization's List of Essential Medicines.[4]It is available as ageneric medication.[5]In 2021, it was the 47th most commonly prescribed medication in the United States, with more than 14million prescriptions.[6][7][8]

For people with high blood pressure, taking atenolol (or otherbeta blockers) helps prevent futureheart disease,heart attacksandstrokes.It can also be used to prevent chest pain caused by angina. Atenolol is sometimes prescribed to preventmigrainesand help withanxiety.[2]

Atenolol works by slowing down theheart rate,making it easier for thehearttopump bloodaround thebody.[2]

[change|change source]

References

[change|change source]
  1. 1.01.11.21.31.41.51.6"DailyMed - TENORMIN- atenolol tablet".DailyMed.30 June 2021.Archivedfrom the original on 27 January 2022.Retrieved20 November2023.
  2. 2.02.12.2"Atenolol: medicine for high blood pressure and angina".nhs.uk.2022-04-06.Retrieved2024-05-29.
  3. Fischer J, Ganellin CR (2006).Analogue-based Drug Discovery.John Wiley & Sons. p. 461.ISBN9783527607495.
  4. World Health Organization(2021).World Health Organization model list of essential medicines: 22nd list (2021).Geneva: World Health Organization.hdl:10665/345533.WHO/MHP/HPS/EML/2021.02.
  5. "Atenolol Monograph for Professionals".Drugs.com.AHFS.Archivedfrom the original on 18 April 2019.Retrieved23 December2018.
  6. "The Top 300 of 2021".ClinCalc.Archivedfrom the original on 15 January 2024.Retrieved14 January2024.
  7. "Atenolol - Drug Usage Statistics".ClinCalc.Retrieved14 January2024.
  8. Source Wikipedia